v3.26.1
Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Underwritten Stock Offering
Underwritten Stock Offering
Common stock
Underwritten Stock Offering
Additional Paid-in Capital
At-the-Market Sales Agreement
At-the-Market Sales Agreement
Common stock
At-the-Market Sales Agreement
Additional Paid-in Capital
Beginning balance at Dec. 31, 2024 $ 323,127   $ 575,693 $ 245 $ (252,811)            
Beginning balance, shares at Dec. 31, 2024   35,850,037                  
Stock-based compensation expense 2,949   2,949                
Unrealized loss on marketable securities 29     29              
Foreign currency translation adjustment (10)     (10)              
Net Income (Loss) (12,928)       (12,928)            
Ending balance at Mar. 31, 2025 313,167   578,642 264 (265,739)            
Ending balance, shares at Mar. 31, 2025   35,850,037                  
Beginning balance at Dec. 31, 2024 323,127   575,693 245 (252,811)            
Beginning balance, shares at Dec. 31, 2024   35,850,037                  
Net Income (Loss) (34,491)                    
Ending balance at Jun. 30, 2025 294,781   581,871 212 (287,302)            
Ending balance, shares at Jun. 30, 2025   35,850,037                  
Beginning balance at Mar. 31, 2025 313,167   578,642 264 (265,739)            
Beginning balance, shares at Mar. 31, 2025   35,850,037                  
Stock-based compensation expense 3,229   3,229                
Foreign currency translation adjustment (52)     (52)              
Net Income (Loss) (21,563)       (21,563)            
Ending balance at Jun. 30, 2025 294,781   581,871 212 (287,302)            
Ending balance, shares at Jun. 30, 2025   35,850,037                  
Beginning balance at Dec. 31, 2025 $ 272,051   605,189 278 (333,416)            
Beginning balance, shares at Dec. 31, 2025 37,386,908 37,386,908                  
Issuance of common shares, Value           $ 123,557   $ 123,557      
Issuance of common shares             6,782,050        
Stock option exercises $ 1,715   1,715                
Stock option exercises, shares   217,827                  
Stock-based compensation expense 4,256   4,256                
Unrealized loss on marketable securities (178)     (178)              
Foreign currency translation adjustment (27)     (27)              
Net Income (Loss) (22,253)       (22,253)            
Ending balance at Mar. 31, 2026 379,121   734,717 73 (355,669)            
Ending balance, shares at Mar. 31, 2026   44,386,785                  
Beginning balance at Dec. 31, 2025 $ 272,051   605,189 278 (333,416)            
Beginning balance, shares at Dec. 31, 2025 37,386,908 37,386,908                  
Stock option exercises, shares 607,944                    
Net Income (Loss) $ (48,350)                    
Ending balance at Jun. 30, 2026 $ 374,913   757,157 478 (381,766)            
Ending balance, shares at Jun. 30, 2026 45,776,902 45,776,902                  
Beginning balance at Mar. 31, 2026 $ 379,121   734,717 73 (355,669)            
Beginning balance, shares at Mar. 31, 2026   44,386,785                  
Issuance of common shares, Value                 $ 15,637   $ 15,637
Issuance of common shares                   1,000,000  
Stock option exercises 2,534   2,534                
Stock option exercises, shares   390,117                  
Stock-based compensation expense 4,269   4,269                
Unrealized loss on marketable securities (547)     (547)              
Foreign currency translation adjustment (4)     (4)              
Net Income (Loss) (26,097)       (26,097)            
Ending balance at Jun. 30, 2026 $ 374,913   $ 757,157 $ 478 $ (381,766)            
Ending balance, shares at Jun. 30, 2026 45,776,902 45,776,902